Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinical utility of next-generation sequencing for bone and soft tissue sarcoma.

Acta oncologica (Stockholm, Sweden) - 1 Jan 2022

Gusho Charles A, Weiss Mia C, Lee Linus, Gitelis Steven, Blank Alan T, Wang Dian, Batus Marta

Abstract excerpt

Background: Sarcomas are a rare and heterogeneous tumor group composed of a variety of histologic subtypes. Targeted next-generation sequencing (NGS) of bone and soft tissue sarcomas is a nascent field with limited evidence for its use within clinical practice. Therefore, further research is needed to validate NGS in sarcoma and assess the clinical utility of these techniques with the hope of improving treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to High-Throughput Nucleotide Sequencing
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Sarcoma

Share to Soft Tissue Neoplasms

Source

Identifiers

PMID: 34686105
DOI: 10.1080/0284186X.2021.1992009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinical utility of next-generation sequencing for bone and soft tissue sarcoma.PMID 34686105Read ↗

The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.Semantic proximity Read ↗

Real-World Implementation of Next-Generation Sequencing in Sarcoma: Molecular Insights and Therapeutic Outcomes.Semantic proximity Read ↗

Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic ArsenalSemantic proximity Read ↗

Implementing precision oncology for sarcoma patients: the CCCLMUmolecular tumor board experience.Semantic proximity Read ↗

Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.Semantic proximity Read ↗

Next-Generation Sequencing for Patients with Sarcoma: A Single Center ExperienceSemantic proximity Read ↗

Precision Oncology in Sarcomas: Divide and ConquerSemantic proximity Read ↗

The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical Implications.Semantic proximity Read ↗

Introduction and impact of routine whole genome sequencing in the diagnosis and management of sarcoma.Semantic proximity Read ↗

A novel next generation sequencing approach to improve sarcoma diagnosisSemantic proximity Read ↗

Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma PatientsSemantic proximity Read ↗

Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.